Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2015 Apr 71 108-11.
Ma Xiaobin, Kang Huafeng, Dai Zhijun, Ma Li, Jin Yaofeng, Wang Xiji
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: